Codes / ICD10CM / M02.39

M02.39 Reiter's disease, multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Reiter's disease, multiple sites (ICD Code: M02.39)

Summary

Reiter's disease, multiple sites is a form of reactive arthritis characterized by inflammation in multiple joints, typically developing after an infection. The condition involves pain, swelling, and stiffness in affected joints, often occurring weeks to months after the initial illness. It is considered a post-infectious complication linked to immune responses triggered by the preceding infection, and may include extra-articular manifestations such as eye inflammation, skin rashes, or urinary tract issues.

Causes

Reiter's disease, multiple sites is caused by the body's immune response to infections, most commonly bacterial infections of the genitourinary or gastrointestinal tract. The infection triggers an inflammatory reaction that can affect joints, even after the initial infection has resolved. The exact mechanism involves immune complex formation and systemic inflammation, though the precise pathways are not fully understood.

Risk Factors

  • History of genitourinary or gastrointestinal infections, such as Chlamydia trachomatis or Salmonella.
  • Pre-existing joint conditions or autoimmune tendencies.
  • Genetic predisposition to inflammatory arthritis.
  • Delayed or inadequate treatment of the initial infection.

Symptoms

  • Joint pain, swelling, and stiffness in multiple joints, commonly affecting the knees, ankles, feet, or other sites.
  • Eye inflammation (conjunctivitis) or uveitis.
  • Skin rashes, such as keratoderma blennorrhagicum.
  • Urinary tract symptoms, including urethritis or cervicitis.

Diagnosis

Diagnosis is based on clinical evaluation, including a history of recent infection, joint symptoms, and extra-articular manifestations. Laboratory tests may include inflammatory markers (e.g., ESR, CRP), joint fluid analysis, and tests for infectious agents. Imaging studies, such as X-rays or MRI, may be used to assess joint damage. Exclusion of other arthritic conditions is also part of the diagnostic process.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain and inflammation. Physical therapy may help maintain joint function. Antibiotics are prescribed if a bacterial infection is present. In severe cases, corticosteroids or disease-modifying antirheumatic drugs (DMARDs) may be considered. Management of extra-articular symptoms, such as eye or skin issues, is also part of the treatment plan.

Prognosis and Follow-Up

Prognosis varies, with some patients experiencing mild symptoms that resolve within months, while others may have recurrent or chronic arthritis. Early treatment of the initial infection and prompt management of symptoms can improve outcomes. Regular follow-up is important to monitor joint function, manage complications, and adjust treatment as needed.

Complications

  • Chronic joint damage or deformity.
  • Recurrent arthritis or persistent symptoms.
  • Eye complications, such as uveitis, which may lead to vision impairment.
  • Cardiovascular risks associated with chronic inflammation.

Lifestyle & Prevention

  • Prompt treatment of genitourinary or gastrointestinal infections to reduce the risk of developing reactive arthritis.
  • Maintaining good hygiene to prevent infections.
  • Regular exercise to preserve joint mobility and strength.
  • Avoiding smoking, which may worsen symptoms or increase disease duration.

When to Seek Professional Help

Seek medical attention if you experience joint pain, swelling, or stiffness following an infection, especially if accompanied by eye or urinary symptoms. Early evaluation is important to diagnose and manage the condition effectively.

Tips for Medical Coders

When coding for Reiter's disease, multiple sites (M02.39), ensure documentation specifies involvement of multiple joints. Verify that the diagnosis aligns with clinical criteria for reactive arthritis and that the code is not used for single-site or unspecified Reiter's disease. Confirm that the code is appropriately assigned based on the provider's documentation of joint involvement and any associated extra-articular manifestations.

Book a walkthrough

M02.39 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.